• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内皮生长因子在甲苯二异氰酸酯诱导的小鼠哮喘模型中对气道高反应性和炎症的作用

Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma.

作者信息

Lee Yong C, Kwak Yong-Geun, Song Chang H

机构信息

Department of Internal Medicine, Research Institute of Clinical Medicine, Chonbuk National University Medical School, Chonju, South Korea.

出版信息

J Immunol. 2002 Apr 1;168(7):3595-600. doi: 10.4049/jimmunol.168.7.3595.

DOI:10.4049/jimmunol.168.7.3595
PMID:11907124
Abstract

Isocyanate chemicals, including toluene diisocyanate (TDI), are currently the most common causes of occupational asthma. Although considerable controversy remains regarding its pathogenesis, TDI-induced asthma is characterized by hyperresponsiveness and inflammation of the airways. One of the histological hallmarks of inflammation is angiogenesis, but the possible role of vascular endothelial growth factor (VEGF), a potent angiogenic cytokine, in TDI-induced asthma is unknown. We developed a murine model to investigate TDI-induced asthma by performing two courses of sensitization with 3% TDI and one challenge with 1% TDI using ultrasonic nebulization to examine the potential involvement of VEGF in that disease. These mice develop the following typical pathophysiological features: airway hyperresponsiveness, airway inflammation, and increased VEGF levels in the airway. Administration of VEGFR inhibitors reduced all these pathophysiological symptoms. These results suggest that VEGF is one of the major determinants of TDI-induced asthma and that the inhibition of VEGF may be a good therapeutic strategy.

摘要

异氰酸酯类化学物质,包括甲苯二异氰酸酯(TDI),是目前职业性哮喘最常见的病因。尽管关于其发病机制仍存在相当大的争议,但TDI诱发的哮喘的特征是气道高反应性和炎症。炎症的组织学特征之一是血管生成,但是血管内皮生长因子(VEGF),一种有效的血管生成细胞因子,在TDI诱发的哮喘中可能发挥的作用尚不清楚。我们建立了一个小鼠模型,通过使用超声雾化器用3%的TDI进行两个疗程的致敏和用1%的TDI进行一次激发来研究TDI诱发的哮喘,以检查VEGF在该疾病中的潜在作用。这些小鼠出现以下典型的病理生理特征:气道高反应性、气道炎症以及气道中VEGF水平升高。给予VEGFR抑制剂可减轻所有这些病理生理症状。这些结果表明,VEGF是TDI诱发哮喘的主要决定因素之一,抑制VEGF可能是一种良好的治疗策略。

相似文献

1
Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma.血管内皮生长因子在甲苯二异氰酸酯诱导的小鼠哮喘模型中对气道高反应性和炎症的作用
J Immunol. 2002 Apr 1;168(7):3595-600. doi: 10.4049/jimmunol.168.7.3595.
2
Doxycycline reduces airway inflammation and hyperresponsiveness in a murine model of toluene diisocyanate-induced asthma.强力霉素可减轻甲苯二异氰酸酯诱导的小鼠哮喘模型中的气道炎症和高反应性。
J Allergy Clin Immunol. 2004 May;113(5):902-9. doi: 10.1016/j.jaci.2004.03.008.
3
A murine model of toluene diisocyanate-induced asthma can be treated with matrix metalloproteinase inhibitor.甲苯二异氰酸酯诱导的哮喘小鼠模型可用基质金属蛋白酶抑制剂进行治疗。
J Allergy Clin Immunol. 2001 Dec;108(6):1021-6. doi: 10.1067/mai.2001.120132.
4
Prevention of IL-1 signaling attenuates airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma.在甲苯二异氰酸酯诱导的小鼠哮喘模型中,抑制白细胞介素-1信号传导可减轻气道高反应性和炎症。
J Allergy Clin Immunol. 2005 Oct;116(4):851-8. doi: 10.1016/j.jaci.2005.07.008.
5
Exposure and immunological determinants in a murine model for toluene diisocyanate (TDI) asthma.甲苯二异氰酸酯(TDI)哮喘小鼠模型中的暴露因素与免疫决定因素
Toxicol Sci. 2005 Mar;84(1):88-98. doi: 10.1093/toxsci/kfi050. Epub 2004 Dec 8.
6
AMPK activation reduces vascular permeability and airway inflammation by regulating HIF/VEGFA pathway in a murine model of toluene diisocyanate-induced asthma.AMPK 激活通过调节 HIF/VEGFA 通路减少甲苯二异氰酸酯诱导的哮喘小鼠模型的血管通透性和气道炎症。
Inflamm Res. 2012 Oct;61(10):1069-83. doi: 10.1007/s00011-012-0499-6. Epub 2012 Jun 13.
7
Modulation of airway remodeling and airway inflammation by peroxisome proliferator-activated receptor gamma in a murine model of toluene diisocyanate-induced asthma.过氧化物酶体增殖物激活受体γ对甲苯二异氰酸酯诱导的小鼠哮喘模型气道重塑和气道炎症的调节作用
J Immunol. 2006 Oct 15;177(8):5248-57. doi: 10.4049/jimmunol.177.8.5248.
8
PTEN down-regulates IL-17 expression in a murine model of toluene diisocyanate-induced airway disease.在甲苯二异氰酸酯诱导的气道疾病小鼠模型中,PTEN下调白细胞介素-17的表达。
J Immunol. 2007 Nov 15;179(10):6820-9. doi: 10.4049/jimmunol.179.10.6820.
9
Asp-Tyr-Leu-Lys tetrapeptide inhibits airway inflammation in toluene-2,4-diisocyanate-induced asthma mice.天冬氨酸-酪氨酸-亮氨酸-赖氨酸四肽抑制2,4-二异氰酸甲苯酯诱导的哮喘小鼠气道炎症。
Clin Exp Allergy. 2008 Jun;38(6):1025-32. doi: 10.1111/j.1365-2222.2008.02977.x.
10
Phosphoinositide 3-kinase-delta inhibitor reduces vascular permeability in a murine model of asthma.磷脂酰肌醇3-激酶δ抑制剂可降低哮喘小鼠模型的血管通透性。
J Allergy Clin Immunol. 2006 Aug;118(2):403-9. doi: 10.1016/j.jaci.2006.04.041. Epub 2006 Jun 6.

引用本文的文献

1
Development of Adaptive Immunity and Its Role in Lung Remodeling.适应性免疫的发展及其在肺重塑中的作用。
Adv Exp Med Biol. 2023;1426:287-351. doi: 10.1007/978-3-031-32259-4_14.
2
An antioxidant ameliorates allergic airway inflammation by inhibiting HDAC 1 via HIF-1α/VEGF axis suppression in mice.抗氧化剂通过抑制 HIF-1α/VEGF 轴抑制 HDAC1 来改善小鼠过敏性气道炎症。
Sci Rep. 2023 Jun 14;13(1):9637. doi: 10.1038/s41598-023-36678-0.
3
Molecular and Functional Characteristics of Airway Epithelium under Chronic Hypoxia.气道上皮在慢性低氧下的分子和功能特征。
Int J Mol Sci. 2023 Mar 30;24(7):6475. doi: 10.3390/ijms24076475.
4
Triple-tyrosine kinase inhibition by BIBF1000 attenuates airway and pulmonary arterial remodeling following chronic allergen challenges in mice.三重酪氨酸激酶抑制作用由 BIBF1000 减轻慢性变应原挑战后小鼠气道和肺血管重构。
Eur J Med Res. 2023 Feb 9;28(1):71. doi: 10.1186/s40001-023-01037-2.
5
Integrating 3D genomic and epigenomic data to enhance target gene discovery and drug repurposing in transcriptome-wide association studies.整合 3D 基因组和表观基因组数据,以增强转录组全基因组关联研究中的靶基因发现和药物再利用。
Nat Commun. 2022 Jun 7;13(1):3258. doi: 10.1038/s41467-022-30956-7.
6
Alteration of lung tissues proteins in birch pollen induced asthma mice before and after SCIT.变应原免疫治疗前后桦树花粉诱导哮喘小鼠肺组织蛋白质的变化。
PLoS One. 2021 Oct 7;16(10):e0258051. doi: 10.1371/journal.pone.0258051. eCollection 2021.
7
Emerging concepts and directed therapeutics for the management of asthma: regulating the regulators.哮喘管理的新观念和靶向治疗:调控调控因子。
Inflammopharmacology. 2021 Feb;29(1):15-33. doi: 10.1007/s10787-020-00770-y. Epub 2020 Nov 5.
8
Oxygen matters: hypoxia as a pathogenic mechanism in rhinosinusitis.氧很重要:缺氧作为鼻窦炎的发病机制。
BMB Rep. 2018 Feb;51(2):59-64. doi: 10.5483/bmbrep.2018.51.2.014.
9
The role of the endothelium in asthma and chronic obstructive pulmonary disease (COPD).内皮在哮喘和慢性阻塞性肺疾病(COPD)中的作用。
Respir Res. 2017 Jan 18;18(1):20. doi: 10.1186/s12931-017-0505-1.
10
The receptor for advanced glycation end products is required for β-catenin stabilization in a chemical-induced asthma model.在化学诱导的哮喘模型中,晚期糖基化终末产物受体对于β-连环蛋白的稳定是必需的。
Br J Pharmacol. 2016 Sep;173(17):2600-13. doi: 10.1111/bph.13539. Epub 2016 Jul 27.